11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

8 trials found

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2200057193	2022-03-02	2022-03-02	Study on the dominant population of tacrolimus in the treatment of myasthenia gravis	Study on the dominant population of tacrolimus in the treatment of myasthenia gravis	myasthenia gravis	Experimental group:Tacrolimus;	Shijiazhuang People's Hospital	NULL	Pending	1	90	Both	Experimental group:100;	Phase 4	China
2	NCT04768465 (ClinicalTrials.gov)	January 1, 2021	21/2/2021	Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis	Effectiveness and Safety of TacrolimusCombined With Low-dose Prednisone for Treatment of Myasthenia ...	Myasthenia Gravis	Drug: Pyridostigmine , Prednisone, Tacrolimus;Drug: Pyridostigmine , Tacrolimus	Da, Yuwei, M.D.	NULL	Recruiting	18 Years	N/A	All	160		China
3	JPRN-UMIN000015019	2014/09/02	02/09/2014	Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG	Initial therapy for myasthenia gravis of combined therapy for tacrolimusand IVIG - Combined therapy ...	Myasthenia gravis	Tacrolimus and IVIG	Kansai medical university	NULL	Recruiting	Not applicable	Not applicable	Male and Female	20	Not applicable	Japan
4	JPRN-UMIN000007671	2012/04/01	09/04/2012	Randomized comparative study on efficacy and safety of reduced-dose steroid combined with tacrolimus ...	Randomized comparative study on efficacy and safety of reduced-dose steroid combined with tacrolimus ...	Myasthenia gravis	Administration of prednisolone35 mg/day with tacrolimus3mg a day Administration of prednisolone50 mg ...	Department of Neurology, Chiba University Graduate School of Medicine	NULL	Recruiting	50years-old	Not applicable	Male and Female	40	Not applicable	Japan
5	JPRN-UMIN000007679	2012/04/01	09/04/2012	Randomized comparative study on efficacy and safety of tacrolimus, prednisolone or placebo in ocular ...	Randomized comparative study on efficacy and safety of tacrolimus, prednisolone or placebo in ocular ...	Myasthenia gravis	Administration of tacrolimus 3 mg/day Administration of prednisolone 5 mg/day anticholinesterases	Department of Neurology, Chiba University Graduate School of Medicine	NULL	Recruiting	20years-old	Not applicable	Male and Female	60	Not selected	Japan
6	NCT01325571 (ClinicalTrials.gov)	March 2011	16/3/2011	A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis	A Randomized, Double-blinded, Placebo-controlled, and Multi-centered Clinical Trial Evaluating the E ...	Myasthenia Gravis	Drug: Tacrolimus capsule;Drug: Placebo	Astellas Pharma Inc	Astellas Pharma China, Inc.	Completed	18 Years	70 Years	Both	83	Phase 3	China
7	NCT00309088 (ClinicalTrials.gov)	April 2006	29/3/2006	FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients	FK506 Phase 3 Study: a Double Blind Placebo Controlled Study for Steroid Non-Resistant Myasthenia Gr ...	Myasthenia Gravis	Drug: tacrolimus;Drug: placebo	Astellas Pharma Inc	NULL	Completed	16 Years	64 Years	Both	80	Phase 3	Japan
8	NCT00309101 (ClinicalTrials.gov)	February 2006	29/3/2006	An Open Study for Steroid Resistant, Non-Thymectomized MG Patients	FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients	Myasthenia Gravis	Drug: tacrolimus	Astellas Pharma Inc	NULL	Completed	16 Years	64 Years	Both	11	Phase 3	Japan

First Previous1Next Last